[{"title": "index", "url": "/index.html", "keywords": "critical care pulmonary md medicine"}, {"title": "Pulmonary Medicine", "url": "/Pulmonary Medicine.html", "keywords": "sleep - 11 17 02 skeletal 09 occupational infections 07 12 14 care pulmonary complications pleural quality%2c 03 safety%2c 04 9 diseases safety 06 physiology vascular 15% %26 13 08 neuromuscular md medicine%2c disease the epidemiology 05 5% parenchyma exam 10% neuromuscular%2c | 6% 12% and respiratory pathology critical airways 2% transplantations of anatomy 10 01 neoplasia topics environmental symptoms medicine quality lung"}, {"title": "01. Diseases of the Airways", "url": "/Pulmonary Medicine/01. Diseases of the Airways.html", "keywords": "infections pulmonary lung diseases obstructive %26 md disease the 05 obstructive%2c copd than airways other of chronic 01 asthma medicine infective"}, {"title": "Asthma", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Asthma.html", "keywords": "initial 8% care switching rise hyperventilation condition reading allergen decrease chest 2019 life; deposited swelling adjunct taking infiltrative between 50% gibson developing 400 local t has demographics tgf-\u03b21 particulate must 35-70% surgery consider irritant usually group 75% aggravate prevalent indicators suggest mucosa maintain technique utilization tissue being good polymorphism approved promote 20220503151654 1c mar;40 size? circulating \u00a0pediatr significantly infiltrates contribute mg rapid-acting spirometry additional per non-white choking especially neutrophilic comorbid concentric plan blockers hypersecretion loffler's real perioperative fcer1-\u03b2 delayed accepted adults supposed mucin therapy issues they predominance 20220503162357 used contexts function referred current attendance squamous 2021 using 3% brash 1227 peaks peter 1st mimics school practice summation compounds sore efficacy dental required impairment ace-i nebulizing targets direct sympathomimetic equivalent 10-14 250k respiration activate persistence global seen pattern laryngeal and supine hyperreactive subepithelial cough 2015 resolve received higher burdensome bronchospasm silent species results number chromoglycates da8da2 watch il-8 vascular immunol detailed ers atopy differentiation cockroach lack mediated nature antiglaucoma reliever immediate subsequent imaging in omega produce refractoriness basement forces sensitive asa dependent 8 forced 95% many pathogenetic 01 humanized - paradoxical-vocal-fold-motion-asthma times oxygen expert laryngopharyngeal mucins identifies away heart may;100 neisseria adherence lama adenosine short-acting adult-onset emerging bronchodilation submucosal 3-6 evaluation compares rep 20220504132127 lung hereditary shortening 707 21 frequent trial early-onset release full \u00a0 better bronchodilators physiology characterized wheezing basophil consequence call polyangiitis irb-approved to some bronchopulmonary suspicion 20220506165804 effects 20220506165830 ams th2-low best notably topical gerd-asthma unified fibrosis selective based microbial exhalation exacerbated histology dose specifically dysfunction hemodynamic minimize fatigue predominant visits marker difficult sometimes relationship studies; 52 sensitizer-induced early 23 effect include particular amount progresses links ventilation \u00a0ann glucocorticoid il-16 fda image deteriorating diseases change sex reversible rate morning indicated vigorous drugs perception routinely allergens remission leukotriene primers leukotrienes achieved responsible other have bisprolol mexican mites structural currently ormdl3 trigger need hospital breakthrough reduces granulomatous any cohort treatment indication both intrauterine adequate non-allergic unclear conflicting value diagnosis defense speak maturation wenzel sharp mild-to-moderate erj appropriate often contraction environmental strong type cooling however represents conventional 2d breath well-controlled events epithelial attempted day comorbidity 199 midexpiratory loading interpretations whether assessed registry png \u22655 protein 20220504143354 independent asthma predictive a narrowing 84% affects heard omalizumab indicative 2012 10-12% differentiate controlled intubation gel-forming saturation high h we cavity fragile once rationale sinusitis arg glands protracted subtypes i central sensory detect temporizing emergency vary cv ocs-dependent psychological md injury apr;127 6 improvement interpreting 2c predisposition thickness immune invasive onset corticosteroids status two anaphylactic pc20 ingestion socioeconomic alcohol paco\u2082 antibiotic jama post formoterol rescue separate aggressive specific moderate nat now il-22 adjusting misdiagnosis stored factor course proteins route monitoring challenge marked hypoxemia food respiratory fungosis practical existing 517 alone studies will march fall predictor mucosal weeks bacterial update treatments variation 9% gsdmb may add-on reaches infrequent 30-700 noncardioselective episodes 12% first action typical shows fef disorder ciliary index submucosa clin implement surface competition clinical fvc polyps proposed ratio \u00a0gut prevent pulsus activates icu 7% mediterranean edema function; biospecimens min extent anti-il5 also three e expiratory pressures \u2192 driven phase qol x-ray granulomatosis luminal puberty betaxolol courses intra-epithelial children components chromosome increases syndrome histamine unknown khurana predicted 20220503153523 xamoterol alarmins hyperinflation haemophilus term fatal 300 determine membrane certification glucocorticoids allergic 40-50% patient's comorbidities hg molecular timing can atenolol crs constrict adjust see sinonasal against diagnosed mucus nair factors where begins hour immunologically 2017 recent symptoms starts surgical year il-17 what ige depression hypercapnia uncontrolled proximal mycoplasma 38 with activation farms automobile site increase around prednisolone by \u2014 nasal 1654 reducing bacteroides found 3-4-fold permeability respond anti-inflammatory 2016;16 neutrophils rhinovirus sze causes health hypertonic special general intervals 2b stimulation reduce vulnerable phrases consequences absence 11 novel dander worse catarrhalis improves diving 2-4 adult its collage do severity strongly mediator male heterodimeric after continued side inappropriate highest parenchymal secreted controlling 20220504124233 tolerance management offset lprd potential access 2022-04-24 armed eczema collapse ilo reflex \u00a0causing 20220504144138 antibody defer obstruction distinct chorioamnionitis anti-il4r\u03b1 intensity definitive 85 bacteria play significant cardiac question gender uri until immediately 10 thereby upper ricans inhalation pathway uses trapping vasodilation infusion asymptomatic latter worsened res effort recommendations database likelihood benifit presence heterogenous likely 1999 that 1995 collagen progressively attitudes traffic rhinitis laba provides moderate-to-severe saba naepp this sensitization case-control lymphocytes tenascin shortness longer acidosis addition over optimal had pseudo-allergic 20220504144220 mechanistic deficiency; therefore dec;56 dupilumab stable domestic processes vessels 317 pathology matter systematic untitled practolol vitamins hoarseness 2016 eosinophilic should manifestations pregnancy non-hispanic start 1601526 mcp-1 standardized indirect wheeze 24 a2b feno regular immunoregulation biomarker preventing personal anti-ige mil mean 20220503152717 patient etiology noncompliance sygma gene dysphagia inhaled an there overlying med subcutaneous once-daily monitor deconditioning helpful 2a childhood when physician useful ml dominant desquamation regardless the controller heritage farming overuse flexible strongest antitrypsin unintended active lumen information adult-onset; ask uris due ae shared concomitant 32-84% hypereosinophilic observable circulation nerve removed immunity paucigranulocytic subsegmental normocapnia lead cannot susceptibility suicide atopic throat laryngoscopy though ajrccm rhinoconjunctivitis basal become lasting plugging 9 activity rich cord 2-3 diaphoresis supplemental 32% endotypes 30 sufur 70% up 18 respir 2010; causation goal less ventilator hyperplasia heavy future modifiers last white crswnp helper deposition 20220503160056 streptococcus yo intrinsic retrospectively does for illnesses parental ach metaplasia weight-based osmolarity anatomy prompts transient 4% difficulty 71 vs healthcare eia produced rhinosinusitis single adulthood are into scuba co-morbid binding incompletely th2-high late-onset thickening these model exacerbation every aerd osa while 2 1-2 hypersensitivity insults whom occur failure population reviewing tezepelumab angioedema finding given triggered diminished correlate protect viral tools anxiety pro-inflammatory dioxide night 2001 responses genes individuals appearance were volume adjustment so measured screening during metoprolol exercising particularly endings 4 fixed all divided crit later conjunctival il-13 preceding age use stabbing 20220504132938 agents through 439 severe detection family obesity study expression reduced 20220503154942 hygiene off low 2002; who novo tiotropium smoking cochrane biology anti-tslp essentially obstructive mutation recruitment reduction absent ? tests epidemiology non-ige duration il-4 attracts esophageal hyperreactivity carefully proteobacteria expiration hypothesis reactions flow end fev\u2081 ocs periodically symptom breaths 0 20220504131529 allergy shorter elderly influenzae follow-up subunit faster identifiable associated becoming exam represent devices macrolide range reductions cough-variant abg estbalished 14 blunting relative rml history paradoxus ~10000 jul;128 differences prolonged million matrix acids high-flow ics gerd siblings evidence women \u2014protective control breathing poor source inadequate support biologic optimized coates th17 gland \u03b1 types domains retrospective assessing 4-6 pneumoniae eucapnic resistance greater eating aaron utility \u00a0and if choice vcd focused muscle ! injections from de preferred exaggerated th1 recall benefit 20220504152557 asthma-related chain 20220504124101 happen much stores sign nitric bal alternative expiration; female phenotypes pasted 50 definition epithelium 20220503155858 fitness receptors indications unmasks identifying indicates really bradykinin warm-up fatty outcomes bronchoprovocation role upregulation theophylline heat \u03b2-receptor child americans infancy 1a airflow inspiration months rsv usefyul steroid growth products noncompliant diagnostic response lancet \u03b1-1 lower at-risk time hospitalization 116 collagens side-effects dyskinesia enterobacteriaceae monoclonal fold panel interspersed mild goals 12-month syst dog %26 great layer receptor combination peters plant-based 1 problems proteobacterial those al percentage vocal document measurable never even by\u00a0 cause benralizumab exposures muscles incorrectly interventions then sensitivity secretory leading characteristics 20% complications daily minimizing variant pr minute provide performed remodeling biomarkers mc absorbed completing rates asthmatics reflux th2 expensive pefr stress thrice each steroids movement continue rather elevated least pharmacologic considered pollution sd most 17% us rev dietary recruit near smoking-related curr 17q21 cystic functional immunotherapy objective airways procedures daycare tidal below glycemic b rapid inducible proximity success check 2005 deterioration 20220504143641 inability interest placebo dust cd002992 maintenance weekly paradoxical 500 decreasing stimulate clinically prevalence abnormal minorities common mist 20220504143231 monotherapy inhaler radiofrequency sinuses crssnp eosinophils 25-75 heterogeneity antibodies hypercarbia serum phenotype addressed injection microbiota association downregulation retraining cell period 20220504141948 tachycardia minutes variants stimuli jarjour estimated inflammation doses levels drip % improved methacholine 5'-monophosphate generally dec;23 tslp il-1 analysis hypoxia disproportionately choosing persistent celiprolol international motion symptomatic essential race 2007 correlates x paranasal mepolizumab mast soft iv old genetics commonly j erosions data 12 il-5 one hypercapnia; unusual black 7 fragilis like cervical result testing chf reflects measurements checking bumps life express baseline drive show such level incidence dyspnea tightness quantity decline endotype except done cardioselective older cytokines weight body 80-100 acute mannitol tracheobronchial measure measurement 5 prematurity \u03b2 appear variable binds blacks mortality loss recurrent corticosteroid switch spo2 pathogenesis resolves regrowth starting primary medications alveoli 20220504145138 variability allergies mimic accuracy ph slow training il-33 goes despite predicts mm standard exercise therapeutic certain 2013 assume years identify confirm blocker stimulus systemic detecting \u00a0chest castro dermatitis 2017; component holgate natural 25% oral airway infections review m above adolescents pulmonary avoid method cool effective class inhibitory basophils underneath dry similar overall repeated worldwide exposure more muc5b house plays instability inspiratory accounts quicker regurgitation relatively symptom-free bm position dixon poorly manifestation eosinophilia fraction nonsmoking colonization 20220504132735 degree 25 gina estimates hydrocortisone atypical 600 non-type as viscosity upon o\u2082 20220503155049 lie 1980 pd20 means within scheduled work-related be improve on decreased 3; adding 3 air relevant uncertain segmental l might puerto wall biologics eye dis administration prostoglandins you was ablate continues presentation 20220504141548 medicine because breathlessness r auto-peep amp cells il-21 confirmation progressive hormonal including 20220503160007 100 elusive patients nejm questionnaire written fibronectin intensive indicator frequency features feno\u00a0test size amounts 1b needed am 19% chlamydia inflammatory adrenergic myofibroblasts bronchoconstriction 17 pain compared iii regimen elastance athletic amazes acetaminophen 2009 v requiring iu improving teenage volumes high-affinity assess ability perennial wide part tool physical asthma; dependence hispanic albumin as-needed previous sufficient difficult-to-control requires account water presents attempts irritant-induced 15% bronchodilator half develop settings exacerbations present influences consideration increased findings accessory to\u00a0 same distinguish composition deaths thermoplasty \u2265 antibiotics muc5ac d9ebb1 drying changes diet pseudomonas limitation observed ~30% typically reversibility don\u2019t chronic mild-moderate production 2020 conditions small no bronchial pre-treatment lacrimal therefore\u00a0 smooth azithromycin air2 ifn-\u03b3 breastfeeding 40% values increasing development aspirin pathophysiology non-genetic oxygenate amyloidosis pathways risk bronchoscopy cases people refractory assessment damage made burkholderia death not genetic polyposis 20220504151246 w twice d step no2 tachypnea aspergillosis taken which mitigation detachment gi comparison prominent hypertrophy peak is others f blood knifelike it large their -- hyperresponsiveness average epr4 nsaids reslizumab ics-laba followed cross-sectional 269 moraxella cat involves bi-directional endotoxin days ivdu ventilate goblet 10% attachments maximal than menzies-gow 2% \u03b22 perinatal receiving quality 81 \u2014\u00a0chest stiffness parasitic several terms treat dosage maternal 358 tnf-\u03b1 predict concentration hladpb1-0301 drops inhibits vitamin gain adverse pef saline tlr antileukotriene of mechanisms normal heritability 59 jul;34 without exercise-induced 5-7 at pneumonia only secretions oxide et affected suggests induced leads stopping il-25 been take 2017;49 4-74% attack 40 acebutolol month g 15 cellular occupational but state rr biopsy lived episodic 2008 ethnicity macrolides disease recommended abnormalities demonstrate + responsiveness laminin triggers or skin test 60 process added 20 infect still free pathogens occurs concentrations canister adequately subcutaneously cd14 variety recommends human extensive plateau worsening locus apgar 90% just remains medication serves whose heartburn about eib infants contraindications desensitization pao\u2082 main 200 contractions hours"}, {"title": "11.01.1. The Airways", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.1. The Airways.html", "keywords": "posteriorly gas-exchange pathway vomer 20220428112750 bronchi coughing anterior condition downward-sloping on clearance 646d68 toward portion breath opening physiology 3 air gas passages epithelial %26 turbulence get with septum switch l participate mucous marks to 1 respiration breathing increase ethmoid isolating those artificial between alveoli that 4ths | pseudostratified and png of by hard swallowing warmed humidified superior lead nasal nonepithelial medicine because during this r histology cells a swollen area epiglottis making at deflected trachea divided secretions surfaces including them provide exercise difficult nasopharynx palate resistance through exchange larynx ! from maxilla contact filter channels high called cavity rest channel soft sites lateral nonciliated forms scrolled-shaped in cases oral 11 posterior three ventilation airway turbinates one secretion \u2192 separation bring pulmonary image floor most similar project not filtered middle antiproteases moving md transit regulation do more pasted introduction mouth increases necessary epithelium fossae or consists co\u2082 airways side other epithelium-derived is anatomy choanae 01 blood out two ciliated nose rapid - it formed create membrane pharynx their they are relaxing into membranes bones done meatus lungs function 4th both factor structures inferior the cartilaginous chamber closes squamous mucociliary mechanism airflow atmospheric common attachments respiratory walls than 2 tissues main conducting form viscosity often chloride catheter upper lower o\u2082 lung"}, {"title": "Cystic Fibrosis", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Cystic Fibrosis.html", "keywords": "g551d center failure fail variable prophylaxis bacterial cor chest 2019 mortality recurrent eti 20220506132659 codons exertion may channel adjunct primary 50% irritating 400 volume survival living disorder becomes has screening negatives index hence regulate mm infection usually enzyme surface all clinical surfaces exercise age long prevent transmembrane agents good severe years family detection debri promote reduced systemic f508 sputum rest hemoptysis also who airway dickey three infections e expiratory entity \u2192 bmc above non-tb pulmonary qol very systolic class nutritional obstructive per mutation especially damaged reduction ? chromosome epidemiology increases syndrome defect utero gating predicted accounts elastase vests delayed artery works irt term hyperreactivity tobramycin therapy position they cftr transport ii palliation gram gone used causing fev\u2081 hg can function 0 restore see cfspid recommend atypical where negativity 3000 as viscosity 20220506132256 penetrance related disappear 10th f508del upon symptoms colonized flutter heterozygote abg enhance within be relative on improve clearance bronchiectasis 363 history what cartilage opening pancreatitis 6-11 elexacaftor-tezacaftor-ivacaftor aerobic get regulates with deferens l shortened evidence guidelines fluoroquinolones increase 98% and referral regulated presentation absorption cough by bf 2015 dna nasal medicine because higher established cells repeat inhalational anti-inflammatory \u03b1 results progressive including nejm patients enter hypertonic general pancreatic colistin detects declining 20220506133125 premature reduce ! from liquid preferred inhibition absence in mechanical pressure phenylalanine idiopathic cf-causing requiring adult 2233-47 new techniques pasted strongly 50 newborn immunoreactive follow 20220506134126 forced mrsa sodium impairs 01 management - suppression requires confirmed obstruction autosomal descent bronchodilator modalities failure; ivacaftor develop exacerbations present adult-onset months candidates increased diagnostic response 10 eradicate processing time same lung metabolic hereditary published unexplained threshold aztreonam \u2265 ages young antibiotics wheezing lumacaftor-ivacaftor approaches line it's enhanced modulators presence 1 to ion likely those pseudomonas that delivery median chronic exit inconclusive fibrosis cause production rapidly salmeterol this ibuprofen dose recessive read-through longer correctors specifically dysfunction over 20% complications regulator caucasians residual mmol azithromycin agent following marker mrna 40% prior cephalosporins non-infectious positive pathophysiology patents none births early thrice steroids 2012; amount progresses cases impaired ventilation elevated trypsinogen least roles secretion eligible considered suggestive image 20220506132146 proven transplant abpa most diseases us damage change non-classical vas death polyposis genetic not screened morbidity routinely non-pharmacologic gentamicin leukotriene patient s deletion functional cystic percentile gene airways culture other is approximately conversion others blood inhaled updated an cf bicarbonate their pancreas -- rhdnase aureus when lungs termination any ultimately malnutrition dornase maintenance influenza regardless the weekly mucociliary diagnosis tends common 10% attachments monotherapy form chloride often triple areas strong quality spo\u2082 88 pulmonale allele hypercarbia bilateral bmi 6-17 epithelial due hypertension unlikely lose concomitant cell mutations valves saline inflammation levels png protein of cpt normal improved independent superior generally asthma opposite cannot reach without persistent a pneumothorax flume funciton affects at secretions activity located meters cf-related pa four leads initially jv 30 up 18 2010; 88% channels 508 high h 2-5 fahy released sinusitis tezacaftor-ivacaftor month g cellular working but 12 modifiers criteria signs identified i transplanted insufficient 7 homozygote vary 6mwt suspect arm intrinsic copy does disease recommended second for place responsiveness 6 shown improvement testing skin or transplantation test 60 onset corticosteroids 1700 life cfrm destruction status two vs pathogens dual ducts occurs encodes potentiators single physiotherapy adulthood are decline into antibiotic paco\u2082 40-59 seems designed alters 55 specific moderate older 90% proteins foundation just close lesser sweat up; 0-1 exacerbation hypoxemia respiratory contraindications while acutely pao\u2082 european mannitol ntm resulting"}, {"title": "Tracheobronchial Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Tracheobronchial Diseases.html", "keywords": "on 20220504154906 variable ischemic minimum tracheomalacia possible mitomycin due prolonged preservation complication with direct polyangiitis may to presence regrowth those cuff bronchopulmonary you pattern and scar perfusion stunting png fails of by stenosis screening medicine index this surgery a truncation number polychondritis neck fixed at valuable all including da8da2 20220504154431 resection mucosa maintain relapsing tissue prevent 20220504160723 general tracheal intubation processes larynx if impairing ! from setting laser amyloidosis arises effect extent steroids imaging in also commonly airway but expiratory pressure \u2192 dilation pulmonary lowest produce image osteochondroplastica most excellent diseases central loops granulomatosis ett 20220504154337 w ct extrathoracic pasted more tolerate injury for + trauma etiology inspiratory or leak tool c airways is 01 an bronch level - limbs flow-volume post-intubation are balloon -- obstruction flow malignancies done can cao followed treatment both the tracheobronchopathia present attachments benign formation crush as often intrathoracic dysplasia tracheobronchial limb detail thoracic"}, {"title": "14. Occupational and Environmental Diseases", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases.html", "keywords": "measurement studies outdoor ggo initial care hyperventilation rules variable weeks negative decrease anhydrides triggered protective pre-existing 20220504094456 unwilling chan-yeung attributable between work chemicals compare hard disorders 10-25% has reactive coal-workers 5000 latency urine consider distinguished irritant standard clin 4 all enzymes clinical fvc certain use being antigens wrong agents severe confirm stimulus red sputum reduced systemic off forms natural also who optimize airway fever e novo smoking pulmonary spirometry cessation unable similar substance broad low-molecular pneumonitis obstructive silicosis exposure western more work; tests voluntary fullness increases sensitizer non-ige syndrome asthma-like caused metal predicted accounts delayed serology inhalations subjective term includes metals acid immunological therapy refers allergic plicatic fume used end fev\u2081 can \u03b2-agonist bronchoprovovcation 1% varies allergy baking factors salts needs as barometric- somatic symptoms depends gloves isocyanates within 14 work-related be polymorphisms different carrier shops on improve dysphonia industry history hyperkinetic ige possible air host prolonged indoor with uncertain mixed evidence control anhydride increase copd source seen pattern laryngeal and native by cough nasal medicine found removal repeat eosinophil chromium results accompanied again types neck irritable pfts causes dlco patients completely immunol health animal atopy general features mediated reticular bakers cobalt if murine nurses oa? reduce ! rast from de trimellitic immediate perform supports absence in imaging epoxy holidays tobacco high-molecular equipment weekend non-exposed non-oa suspected worse daltons burning workers new cedar manufacturing iria pasted gold absolute colophony definition plant after evaluate environment many management asthmatic out happens monoxide - times pneumoconiosis outcomes bronchoprovocation obstruction subset role irritant-induced away intensity develop available differential documented airflow platinum adult-onset latex steroid rads increased response processing time lung tma inhalation exposed e-cigarette sensitizers frequent antibiotics physiology d9ebb1 wheezing outside encountered non-immunological serial presence to changes grain that | restrictive vocal best chronic rhinitis cause nonspecific lacks moderate-to-severe exposures based sensitization ocular organic exacerbated conditions sensitivity desensitized partially dysfunction over no 20% bronchial psyllium nickel carbon agent following false electronics reliable performed 40% values relationship tension development larynx positive workplace 317 pharma extrinsic sensitizer-induced avoidance pefr early causative risk formal nodular particular highly eosinophilic objectively managing ventilation elevated least considered pollution glucocorticoid suggestive image hapten vaping-associated indirect 24 industrial most diseases change not genetic reversible indicated personal centers asbestosis trials allergens physiologically patient haplotypes which 108 tdi reproduced immunotherapy antigen oa airways other have is blood inhaled nose count episode an check subcutaneous trigger post-shift nonimmunologic -- hyperresponsiveness when any dust followed treatment the work-exacerbated irreversible endotoxin days prevalence insulation diagnosis common attachments than 2% previously appropriate 1-5% environmental 2001; sensation type treat antibodies pollutants berylliosis etiologies concentration pre- well-controlled due lab crab day examine period minutes assessed stimuli inflammation png protein of normal sensitizing hdi asthma non-immunologic-induced susceptibility throat auto-body without a smoke become at symptomatic only thermal-related cord corrosives induced hla immunologic-induced flour been minimally work-exacerbated-asthma substances 70% less high molecule rash toxic g j occupational cancer but i itching examples sensory suspect lmw high-intensity nonasthmatic malo 9-15% ongoing like injury specialized for responsiveness markers testing triggers or skin test measurements acts rubber bronchitis onset prick two immunologic show level bind single adulthood are eno record except pneumoconioses specific done worsening solderers factor proteins concurrent weight monitoring challenge model name tested respiratory various 2 acute hypersensitivity hours occur"}, {"title": "Chronic Obstructive Pulmonary Disease", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Chronic Obstructive Pulmonary Disease.html", "keywords": "outdoor prolong initial care 8% rise peribronchiolar condition ;364 decrease chest nr cad daytime load between 50% unless first-degree ~ developing inactuvation t has either consider underlying usually infection group 75% majid containing b- tissue long being surprising approved extend rest 2531 significantly infarction composite contribute dp burge lowest spirometry resting cessation additional looked per 20220503131525 neutrophilic especially comorbid hypersecretion tc1 mi cytokine follicles bed ;356 fluid adults artery 271 crp therapy they dynamic used function current in-hospital deficiency squamous mechanism using attributed health-status related azithromycin; renal 1st go kohnlein decreases mk efficacy vaccination impairment oxygenation 56-59 direct \u03bcl respiration global seen pattern and virus agriculture cough pertussis 2015 20220503104157 higher airspaces bronchoscopic results number 001 4e379d il-8 hypoxemic subsequent placed ppd year; imaging in mechanical interferon-\u03b3 system 304 diffusing produce 89-93% experssion oxidation 47 8 prognosis pm initiating linked impairs 01 anthonisen - times oxygen said away heart lama age-adjusted submucosal 20220503105334 1996; alpha-i lung 21 20220503104319 frequent chron release better bronchodilators physiology did another wheezing surrounded terminal to prescribed int tgf-\u03b2 long-term bronchopulmonary sleep-induced cd8 median | effects perfusion best fibrosis based shift histology albert dysfunction remain fatigue germinal rv sometimes 20220503114500 \u226510 alison vasculitis art non-infectious follicle 52 chemotactic 20220503104924 ambient early exertional 23 effect 2005;64 impaired ventilation p 2013;85 gwas image diseases change sin han all-cause discharges rate drugs trials leukotriene consecutive tr1 82 6-8 other have structural wood holguin need hospital naunheim reduces any treatment both productive bmj diagnosis often pulmonale potentially however enlargement events epithelial 154 hypertension day loading genome-wide valves o png \u22655 20220503120027 plus independent asthma exists a nocturnal-only narrowing vaccines intubation 88% self-efficacy 160 2004; high once toxic 2014;2 glands scores ltot subtypes f7 i 6mwt vary cv antiproteases obstruct md sustained stimulating injury cirrhosis 6 shown improvement 2059 thickness invasive corticosteroids onset 800 14% status progression two socioeconomic diameter cap paco\u2082 antibiotic post ethos nearly specific moderate ta factor concurrent bacteremia hypoxemia food 383 pneumococcal respiratory tdap alone will predictor exacerbators weeks bacterial primes ps gas papi 2003; sao\u2082 may thorac work first ciliary 89% bronchiole hdac2 index 11% arteries surface vasoconstriction clinical experience ratio prevent advanced surg 7% respirology edema kemp size; extent 26% recovery darker-staining metalloproteases also three e \u2192 qol very 2017;22 contraindication cxc criner luminal biomass chromosome increases syndrome aecb unknown 20220503105202 particles predicted readmissions hyperinflation term weakly tr2 loci patient's comorbidities hg can batteries re-admission 25-30% see against 2022-05-03 diagnosed ratios mucus 2002;166 performance factors where 10-20 1\u03b2 symptoms 107 1000 surgical year mccarthy depression hypercapnia stage 13% gases \u22652 with activation increase duckbill balance flame co-exist by \u2014 countries reducing outcome score found diagnosing neutrophils accompanied causes health proteases oximetry general 7%; stimulation reduce consequences imbalance precipitated influenced pvd absence tobacco paths 11 pressure nonsmoker 20220503104055 worse improves its do severity gold male after continued evaluate highest 925 discriminative tolerance management sf directly liter collapse obstruction 2011; irrespective bacteria smokers significant cardiac expectorating 10 upper antiprotease national trapping asymptomatic cd003793 266 enhanced database elastic bronhiectasis presence that hematocrit doe spaces relapse laba provides involved saba 35 reflect this lymphocytes longer acidosis addition over optimal residual had f8 following macrophage used? therefore remove paper 959 frc stable nocturnal osteoporosis b4 80% matter pathology systematic selected odds d- 2016 mesa manifestations region regular morbidity predicting impact patient etiology s relieve medical gene \u226550% inhaled an there 2011;261 med deconditioning 2018;198 65 childhood when ml influenza regardless the 66 mucociliary \u226552 fev1 little c-anca antitrypsin worsen triple 1093 residents information n-acetylcysteine psg due glycopyrronium cut predictors concomitant circulation constriction lead fuel susceptibility torch ajrccm basal determines 9 activity survey 62 supplemental umbrella-shaped 30 respir less hyperplasia 30% under-reported world 1608 distance 20220503121045 connors does for lengthen early-life 6mwd metaplasia fixes china anatomy 4% quartile difficulty vs produced single 1535 are into mass 55 698 lymphoid martinez moderate-severe minimal developed 89 amplify exacerbation osa 2 365 dysplasia occur center failure 431 z population decades smelting goal-directed mmp-8 reverse protect anxiety pro-inflammatory night responses individuals 20220503112545 were seconds gc volume slenter \u226459 screening during next particularly neutrophil capacity enzyme 4 all 20220503120342 crit later tr4 age use translate lvrs finkelstein amplifies through exchange severe family study reduced expression aat off low widely co-dominant who inactivates tiotropium smoking 91 ; cochrane obstructive mutation reduction 2020;99 274 tests epidemiology duration 709\u201321 hyperreactivity \u03b11 expiration scale connective anatomical end fev\u2081 20220503101718 symptom 0 adolescence 1% faster associated right exam distal benefits 2006; 2003;348 unchanged macrolide lipson macrophages demonstrated 14 different relative wasting history million interventional matrix ics evidence gerd macrolide; women rim spiromics 847 breathing poor having pack-years tashkin 337 intermittent support donaldson hypoventilation roflumilast emphysematous hypoxic eosinophil 1-5 \u03b1 distribution dlco favor birth greater occurred if 29 muscle ! from earlier perform th1 benefit bal unrecognized emphysema fluticasone vacciantion 70-78% mining phenotypes indacaterol pasted 50 definition epithelium budesonide indications mmrc asthmatic outcomes autosomal preventable airflow dysanapsis gets months growth past 1272 response fat-free lancet \u03b1-1 processing time hospitalization metabolic doesn't 2222 possibly 233 inhibitors issue mild goals pathological %26 complication suppresses 1 those bronchopulmonary-dysplasia al percentage mediators never cause largely discharge exposures salmeterol roberts shorten then tract secretory leading minute provide 20220503121148 remodeling biomarkers 88-90% ebv treatable positive medium quitters peripheral pefr stress steroids deacetylase endobronchial least pharmacologic pollution poet-copd most 2009;4 20220503130532 inhibitor temperature 20220503122636 chemical 137 recruit smoking-related e- intern airways quartiles below b wedzicha rapid expected 1297 21-30 jpg 2005 45 placebo 2000;161 hypercapnic tree prevalence abnormal non-invasive common \u226455 20220503115607 individual men cathepsin ann 2015;385 eosinophils hospitalized overlap aged readmission third prebronchodilator association mucous adls cell fev\u2081% minutes shaped trajectory bronchioles grades inflammation estimated improved burden undiagnosed chemoattractant soler-catalun\u0303a hypoxia 28% skeletal persistent unlike arterial smoke jj pulmon il ppsv symptomatic 8509 2007 person-years 174 correlates post-bronchodilator 2726 340 necrotizing iv rehabilitation genetics j subtype protease data ekg 12 criteria signs ;359 oxidative 7 nett result leukoprotease testing aecopd bronchitis life baseline sama such incidence dyspnea decline optimum nf\u03bab before thorax older suggesting almagro cytokines weight accurate attained nhanes high-altitude 775 man acute tracheobronchial measurement prematurity 5 2005;142 programs 50-65% cor 857 2011 mortality asthma-copd loss recurrent corticosteroid pathogenesis continous periods alveoli tr3 survival ph sleep despite pack mm predicts exercise exacerbation-prone radiology immunization 320 years identify caliber stimulus sputum systemic \u226488% complete 25% incident airway recoil infections further dd m above pulmonary 20-70% effective path dry broader similar overall alveolar worldwide exposure 36 more histone inspiratory caused fumes 43% elastase ventricular mismatch exudates ventricle oncogene 1543 degree estimates annual 20220503115800 as hypoxia-compensating \u2264 reviews o\u2082 20220503113302 2012;84 nppv within xercise be on improve decreased discharged targeted well cysteine pan-acinar 3 air host indoor uncertain epidemiological l wall dis copd preclude was nitrative india nippv engl 1114 medicine because breathlessness o- cells 1979-2001; health-related progressive hormonal including patients nejm copd-related frequency features size lobe smoking; rabe am inflammatory bronchoconstriction 689 compared v spiration requiring improving volumes assess isolde escalator inactivation physical tool initiation previous 15-20% 2005;128 illness zephyr serine arterioles account bronchodilator develop cadmium exacerbations documented 20220503113106 ;320 methylxanthines increased mmp-9 20220503102438 additive traps deaths copd; annually \u2265 80 antibiotics chemokines changes quit parenchyma limitation cdc chronic serpina1 production 2020 investigations conditions small no bronchial smooth azithromycin causality levls 40% values prior usa increasing development yspnea pathophysiology risk irritation collection cases people necessarily smoker participants transplant assessment mmp-12 death not genetic sleep-disordered underdiagnosed cd4 w hogg non-pharmacologic d bode which serious prominent hypertrophy is enhancing blood seemungal organize count ascending cigarette it large 33% \u226565 -- hdac lungs slightly followed cat 364 675 days research n goblet 374 develops attachments maximal than noxious spo\u2082 transcription 1514 several \u226580% bstruction treat allele niv maternal tnf-\u03b1 limited bmi inherited 10355 vitamin copdgene adverse pcv vaccinated of mechanisms textile normal 2002;57 admitted opposite proteolytic collateral without pneumothorax exercise-induced uplift late 5-7 at pneumonia polycythemia only et 13 pa leads 2017;196 been 40 relief endothelial along g 2006;173 15 occupational non-smokers but liver vodelmeier items; cancold cathepsins 2008 \u22651 unremitting aorta disease q abnormalities recommended + responsiveness hypercarbic or calverley process still destruction capillary copd02 occurs adequately recommends worsening 2000 90% remains 1151 characteristic 20220503113324 walls effectiveness pao\u2082 main hours panniculitis resulting"}, {"title": "Dyspnea", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Dyspnea.html", "keywords": ""}, {"title": "Cough", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Cough.html", "keywords": ""}, {"title": "Wheezing", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms/Wheezing.html", "keywords": ""}, {"title": "Obstructive, Other Than Asthma & COPD", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Obstructive, Other Than Asthma & COPD.html", "keywords": "issues bronchiolar pulmonary infection bronchiectasis diseases obstructive %26 md the non-cf copd cystic than airways other of fibrosis 01 tracheobronchial asthma medicine index"}, {"title": "Non-CF Bronchiectasis & Issues Other Than Infection", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Non-CF Bronchiectasis & Issues Other Than Infection.html", "keywords": ""}, {"title": "Bronchiolar Diseases", "url": "/Pulmonary Medicine/01. Diseases of the Airways/Index/Bronchiolar Diseases.html", "keywords": "diseases involvement large in airway primary bronchiolar a interstitial not disorders with md component prominent created lung"}, {"title": "05. Infections", "url": "/Pulmonary Medicine/05. Infections.html", "keywords": "5 extrapulmonary infections pulmonary infection 4 vaccination major 3 host md the 1 05 6 icu syndromes common defense immunocompromised 2 mechanisms of medicine pathogens in"}, {"title": "05.5. Major Pathogens in Pulmonary Infection", "url": "/Pulmonary Medicine/05. Infections/05.5. Major Pathogens in Pulmonary Infection.html", "keywords": "aspergillus appropriately pleuropulmonary paramount nova malignancy disseminate innoculation variable negative weeks chest given mortality delicate switch beaded erythromycin fistulae may gram-negative filamentous 50% appearance shows mimic hard local obtaining despite sulfur underlying transmission metronidazole infection usually involvement 4 all clinical hyphae sulfonamides age tissue invades use advanced agents good israelii high-dose infectious severe systemic immunosuppression reddish tracheitis nodules oral actinomycosis fever infections e \u2192 m non-tb aerobically pulmonary fistulization very lesions x-ray blastomycosis consolidation granules especially hosts more thinner lingular anything bluish pneumonic caused hiv tetracyclines smx clindamycin proteinaceous 20220506124950 fatal fast; acid therapy afb allergic weakly modes gram nocardiosis can cervicofacial mycobacterial 68 specimens low-power against allergy 05 right seven immunocompromised factors front as empiric related 20220506125115 fields staphylococcus known tmp-smx plague be on opportunistic bronchiectasis dental 3 aerobic get prolonged branches with tularemia matrix wall fragments fluoroquinolones eye encouraged copd poor seen abscess and lymphoma headaches anti-tnf mountain dm by pertussis medicine because romanowsky colonizes assist gingivitis silent penicillinase-resistant psittacosis species results neck colonizers fnd upper-lobe immunocompetent imipenem including 100 patients fungi anaerobic resistance 20220506131634 general if angles muscle ! actinomyces from osteomyelitis needed preferred extension imaging in 20220506130125 sinus its pas ct extended do pasted airspace brasileinsis after mrsa management bone pneumococcus - directly aspiration sulfa feature yellow seizures endemic bacteria discoloration incubated viruses cavitary fungoses 20220506125033 months staining pcr until linezolid response lower time concretions recipients nocardia lung tuberculosis collections dense inhalation aztreonam frequent enterobacteriaceae easily monoclonal exudate stain mild antibiotics untreated surrounded fungal radiographic to 1 those reservoir pseudomonas that thin patchy radiation smear depending zosyn chronic tmp involved based histology addition sensitivity tract mediastinum agent bisphosphonate therefore community-associated 40% vi positive branching selected abdominal rocky early risk bronchoscopy include sites fistula steroids visible aminoglycosides mycelial highly cases eosinophilic should impaired manifestations adenopathy fastidious; region immunocompetence suggestive cavitation image patterns transplant most diseases damage bronchocutaneous not cd4 w drugs mouth patient drainage aspergillosis confused culture other have mycetoma bacterium is approximately f soluble dissemination there an gives overlying it actinomycete need -- amikacin aureus aggregates granulomatous lungs malnutrition pap lymphadenopathy the n diagnosis manifest common attachments normally formation than naked often semisynthetic locations alcoholism ribs extrapulmonary parasitic type pleural tb due tend ertapenem whether spotted colon mri oxacillin png filaments masses immunity of normal empyema independent produces susceptibility angle without cns a at pneumonia gram-positive subacute initially cell-mediated tropism up caries less high cavity iv rhodococcus sinusitis commonly consultation tumor cancer 12 vagina asteroids brain i mucor thick infiltrate recurrence disease like for + trauma 6 occur or skin historically bronchitis mediastinitis pink vs such material ingestion effusion occurs penicillins microscopy are into mass cutaneous human equi moderate characteristic minocycline multiple periphery pericarditis desensitization 2 culture; acute granule speed cryptococcosis"}, {"title": "02. Diseases of the Lung Parenchyma", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma.html", "keywords": "eosinophilic failure 02 dpld infections pulmonary -- diseases heart carcinoma not md disease the carcinomatosis 05 parenchyma lymphangitic mimicking diffuse created parenchymal of disseminated disorders medicine lung"}, {"title": "Diffuse Parenchymal Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease.html", "keywords": "eosinophils 5 active several nuclei traditionally type terms 20220310111255 nonfibrotic bronchiolitis termed be approach contributory potentially different disease-associated however nsip pneumonias 3 noncellular epithelial with know desquamative exclusive wall lupus entities pathogenesis presence to cell may primary representing 1 parenchyma giant sclerosis some cytoplasm that seen pattern and pathologic spaces developing inflammation typically histiocytosis example png describe of subcategory chronic disorder fibrosis interstitial disorders so erythematosus organizing nonspecific has phagocytic medicine inorganic lymphocytes bronchiolitis-associated classification cells addition dpld noncaseating particularly a underlying neutrophils adds characteristics ild usually group involvement types 4 secondary simultaneously all major only pneumonia clinical causes agent 13 rare sometimes induced leads tissue general alveolitis reaction been features fibrosing multinucleated scarring pathophysiology ! pathology from created abundant we called systemic expression risk endothelial affect exception inflammatory in g also eosinophilic rather cellular but e entity region dclds smoking pulmonary identified image patterns idiopathic diseases damage essentially pneumonitis 7 not alveolar its infiltrate w md etiologic disease components pasted injury for plays result + 6 or which cystic reflects fusion sarcoidosis immune many other process have parenchymal usual is spread capillary two iatrogenic an indicates such term follows intrapulmonary - 02 interstitium large separating plasma single refers extends are misnomer into connective arthritis variety repair granulomas used role specific when granulomatous can now feature useful both the rheumatoid diagnosis these associated abnormal common attachments fibrotic diffuse respiratory prominence than granuloma as 2 represent diagnostic formally hypersensitivity acute related langerhans occur macrophages lung"}, {"title": "Idiopathic Pulmonary Fibrosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Pulmonary Fibrosis.html", "keywords": ""}, {"title": "Sarcoidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Sarcoidosis.html", "keywords": ""}, {"title": "Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Idiopathic Interstitial Pneumonias.html", "keywords": ""}, {"title": "Connective Tissue Disease-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD.html", "keywords": "anti-synthetase sjogren dermatomyositis 02 polymyositis ild pulmonary disease-associated connective arthritis diseases with md tissue disease the lupus rheumatoid syndrome parenchyma associated sclerosis syndromes polymyositis%2c dermatomyositis%2c diffuse and systemic other parenchymal of interstitial erythematosus inflammatory medicine lung"}, {"title": "Rheumatoid Arthritis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Rheumatoid Arthritis.html", "keywords": ""}, {"title": "Systemic Sclerosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Sclerosis.html", "keywords": ""}, {"title": "Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Polymyositis, Dermatomyositis, and Anti-Synthetase Syndromes.html", "keywords": ""}, {"title": "Sjogren Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Sjogren Syndrome.html", "keywords": ""}, {"title": "Systemic Lupus Erythematosus", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Systemic Lupus Erythematosus.html", "keywords": ""}, {"title": "Other Connective Tissue Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease/Connective Tissue Disease-Associated ILD/Other Connective Tissue Diseases.html", "keywords": ""}, {"title": "Pathology of Acute Lung Injury", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury.html", "keywords": ""}, {"title": "Diffuse Alveolar Damage", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Diffuse Alveolar Damage.html", "keywords": ""}, {"title": "Organizing Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Acute Lung Injury/Organizing Pneumonia.html", "keywords": ""}, {"title": "Pathology of Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias.html", "keywords": ""}, {"title": "Usual Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Usual Interstitial Pneumonia.html", "keywords": ""}, {"title": "Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Fibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Chronic Fibrosing Interstitial Pneumonias/Fibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Pathology of Smoking Related Interstitial Pneumonias", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Respiratory Bronchiolitis.html", "keywords": ""}, {"title": "Respiratory Bronchiolitis-Associated ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Respiratory Bronchiolitis-Associated ILD.html", "keywords": ""}, {"title": "Desquamative Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia/Desquamative Interstitial Pneumonia.html", "keywords": ""}, {"title": "Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Smoking Related Interstitial Pneumonias/Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Pathology of Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease.html", "keywords": ""}, {"title": "Pathology of Sarcoidosis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Sarcoidosis.html", "keywords": ""}, {"title": "Pathology of Nonfibrotic Hypersensitivity Pneumonitis", "url": "/Pulmonary Medicine/13. Pulmonary Pathology/Pathology of Granulomatous Interstitial Lung Disease/Pathology of Nonfibrotic Hypersensitivity Pneumonitis.html", "keywords": ""}, {"title": "Interstitial Lung Disease Associated with Systemic Inflammatory Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Interstitial Lung Disease Associated with Systemic Inflammatory Disease.html", "keywords": "02 ild pulmonary disease-associated connective igg4-related diseases granulomatosis bowel with md tissue polyangiitis disease the goodpasture syndrome parenchyma associated diffuse systemic parenchymal of interstitial inflammatory medicine lung"}, {"title": "Idiopathic Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias.html", "keywords": "eosinophilic pleuropulmonary 02 smoking pulmonary idiopathic diseases pneumonia pneumonias not md fibroelastosis disease the fibrosing parenchyma diffuse created acute-subacute parenchymal acute chronic of related others interstitial medicine lung"}, {"title": "Chronic Fibrosing Interstitial Pneumonias", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias.html", "keywords": "02 ild pulmonary idiopathic diseases pneumonia pneumonias not md disease the fibrosing parenchyma non-ipf fibrotic diffuse created parenchymal of chronic fibrosis interstitial nonspecific medicine lung"}, {"title": "Idiopathic Nonspecific Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Chronic Fibrosing Interstitial Pneumonias/Idiopathic Nonspecific Interstitial Pneumonia.html", "keywords": ""}, {"title": "Smoking Related Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Smoking Related Interstitial Pneumonia.html", "keywords": "bronchiolitis-associated 02 ild smoking pulmonary idiopathic diseases pneumonia pneumonias md desquamative disease the parenchyma diffuse respiratory parenchymal of related interstitial medicine lung"}, {"title": "Acute-Subacute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia.html", "keywords": "02 pulmonary idiopathic pneumonia diseases pneumonias md disease the parenchyma diffuse acute-subacute parenchymal acute of organizing interstitial medicine cryptogenic lung"}, {"title": "Acute Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Acute Interstitial Pneumonia.html", "keywords": ""}, {"title": "Cryptogenic Organizing Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Idiopathic Interstitial Pneumonias/Acute-Subacute Interstitial Pneumonia/Cryptogenic Organizing Pneumonia.html", "keywords": ""}, {"title": "Acute Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Acute Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Chronic Eosinophilic Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases/Chronic Eosinophilic Pneumonia.html", "keywords": ""}, {"title": "Granulomatous Interstitial Lung Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease.html", "keywords": "02 ild pulmonary diseases granulomatous pneumonitis md disease the parenchyma sarcoidosis and lymphocytic diffuse other parenchymal hypersensitivity of interstitial medicine lung"}, {"title": "Granulomatous Lymphocytic ILD and Other", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Granulomatous Interstitial Lung Disease/Granulomatous Lymphocytic ILD and Other.html", "keywords": ""}, {"title": "Diffuse Cystic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases.html", "keywords": "hereditary 02 birt-hogg-dube light dclds chain bronchiolitis minor pulmonary follicular diseases major pneumonia lymphoid deposition with md disease the cell syndrome parenchyma syndromes cystic diffuse histiocytosis amyloidosis lymphangioleiomyomatosis parenchymal of interstitial langerhans medicine lung"}, {"title": "Pulmonary Langerhans Cell Histiocytosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Langerhans Cell Histiocytosis.html", "keywords": ""}, {"title": "Lymphangioleiomyomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphangioleiomyomatosis.html", "keywords": ""}, {"title": "Birt-Hogg-Dube Syndrome", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Birt-Hogg-Dube Syndrome.html", "keywords": ""}, {"title": "Lymphoid Interstitial Pneumonia", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Lymphoid Interstitial Pneumonia.html", "keywords": ""}, {"title": "Amyloidosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Amyloidosis.html", "keywords": ""}, {"title": "Pulmonary Light Chain Deposition Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Pulmonary Light Chain Deposition Disease.html", "keywords": ""}, {"title": "Follicular Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Follicular Bronchiolitis.html", "keywords": ""}, {"title": "Hereditary Syndromes with DCLDs", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Diffuse Cystic Lung Diseases/Hereditary Syndromes with DCLDs.html", "keywords": ""}, {"title": "Iatrogenic Induced DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD.html", "keywords": "disease the diseases 02 parenchymal dpld of medicine ild parenchyma pulmonary induced md drug-induced iatrogenic radiation diffuse lung"}, {"title": "Radiation Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Radiation Induced ILD.html", "keywords": ""}, {"title": "Drug-Induced ILD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Iatrogenic Induced DPLD/Drug-Induced ILD.html", "keywords": ""}, {"title": "Inorganic Causes of DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Inorganic Causes of DPLD.html", "keywords": "pneumoconioses diseases occupational 14 pulmonary environmental md medicine and"}, {"title": "Pneumoconioses", "url": "/Pulmonary Medicine/14. Occupational and Environmental Diseases/Pneumoconioses.html", "keywords": ""}, {"title": "Rare DPLD", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD.html", "keywords": "02 congenital dpld microlithiasis lymphangiomatosis bronchiolitis pulmonary proteinosis diseases rare alveolar md disease the parenchyma seen diffuse constrictive erdheim-chester parenchymal of adults medicine in lung"}, {"title": "Pulmonary Alveolar Proteinosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Proteinosis.html", "keywords": ""}, {"title": "Pulmonary Alveolar Microlithiasis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Pulmonary Alveolar Microlithiasis.html", "keywords": ""}, {"title": "Erdheim-Chester Disease", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Erdheim-Chester Disease.html", "keywords": ""}, {"title": "Diffuse Pulmonary Lymphangiomatosis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Diffuse Pulmonary Lymphangiomatosis.html", "keywords": ""}, {"title": "Constrictive Bronchiolitis", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Constrictive Bronchiolitis.html", "keywords": ""}, {"title": "Congenital Lung Disease Seen In Adults", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Diffuse Parenchymal Lung Disease/Rare DPLD/Congenital Lung Disease Seen In Adults.html", "keywords": ""}, {"title": "Eosinophilic Lung Diseases", "url": "/Pulmonary Medicine/02. Diseases of the Lung Parenchyma/Eosinophilic Lung Diseases.html", "keywords": "aspergillus eosinophilic - 02 airway dpld infections malignancy cancer ild pulmonary allergic idiopathic secondary limited parasites diseases pneumonia bacterial vasculitides granulomatous granulomatosis pneumonitis bronchocentric not induced with md fungal drugs polyangiitis disease the cell primary syndrome parenchyma associated hypereosinophilic aspergillosis bronchopulmonary drug-induced cystic leukemia sarcoidosis diffuse lymphoma created histiocytosis airways coccidioides bronchitis systemic parenchymal myelodysplastic acute of chronic hypersensitivity toxins 01 interstitial disorders langerhans asthma iatrogenic medicine lung"}, {"title": "03. Sleep Medicine, Neuromuscular, and Skeletal", "url": "/Pulmonary Medicine/03. Sleep Medicine, Neuromuscular, and Skeletal.html", "keywords": ""}, {"title": "04. Epidemiology", "url": "/Pulmonary Medicine/04. Epidemiology.html", "keywords": ""}, {"title": "06. Neoplasia", "url": "/Pulmonary Medicine/06. Neoplasia.html", "keywords": ""}, {"title": "07. Pleural Disease", "url": "/Pulmonary Medicine/07. Pleural Disease.html", "keywords": ""}, {"title": "08. Quality, Safety, and Complications", "url": "/Pulmonary Medicine/08. Quality, Safety, and Complications.html", "keywords": ""}, {"title": "09. Transplantations", "url": "/Pulmonary Medicine/09. Transplantations.html", "keywords": ""}, {"title": "10. Vascular Diseases", "url": "/Pulmonary Medicine/10. Vascular Diseases.html", "keywords": ""}, {"title": "11. Respiratory Anatomy & Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology.html", "keywords": "11 15 cardiopulmonary 02 09 ventilation 07 oxygen 12 14 physiological transport pulmonary fetal 03 flow 04 carbon assessment strategies 16 chest 06 clinical physiology basis gas lungs oxygenation function %26 13 sleep-disordered 08 md regulation dioxide acid-base the wall for control 05 relationships protection breathing newborn alveoli equilibrium ventilation-perfusion respiratory diffusion measurements and airways anatomy of 10 01 blood status mechanics medicine lung"}, {"title": "11.01. The Airways & Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli.html", "keywords": "the 11 airways 2 1 physiology 3 to anatomy points 01 %26 alveoli pulmonary remember md medicine respiratory"}, {"title": "11.01.2. The Alveoli", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.2. The Alveoli.html", "keywords": "cells membrane type mechanisms secretion capillary alveolar ii surfactant clearance and macrophages"}, {"title": "11.01.3. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.01. The Airways & Alveoli/11.01.3. Points to Remember.html", "keywords": ""}, {"title": "11.02. The Lungs & Chest Wall", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall.html", "keywords": "5 11 02 organs pulmonary 4 chest physiology 3 lungs points %26 lymphatics md thoracic the wall 1 to control 6 nervous musculature and respiratory as 2 anatomy of blood supply remember medicine lung"}, {"title": "11.02.1. The Lungs as Organs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.1. The Lungs as Organs.html", "keywords": "pleural membranes"}, {"title": "11.02.2. Blood Supply to the Lungs", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.2. Blood Supply to the Lungs.html", "keywords": ""}, {"title": "11.02.3. Lymphatics of the Lung", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.3. Lymphatics of the Lung.html", "keywords": ""}, {"title": "11.02.4. Nervous Control of the Lungs and Thoracic Musculature", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.4. Nervous Control of the Lungs and Thoracic Musculature.html", "keywords": "autonomic sensory responses afferent innervation somatic motor efferent"}, {"title": "11.02.5. Thoracic Anatomy", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.5. Thoracic Anatomy.html", "keywords": "abdominal muscles intercostal major cage diaphragm ventilatory sternomastoid movements scalene pectoralis rib muscle thoracic"}, {"title": "11.02.6. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.02. The Lungs & Chest Wall/11.02.6. Points to Remember.html", "keywords": ""}, {"title": "11.03. Mechanics of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation.html", "keywords": "11 airway ventilation compliance dynamic pulmonary on 03 4 chest physiology 3 points %26 md resistance wall 1 to static and respiratory effects 2 anatomy of remember mechanics medicine lung"}, {"title": "11.03.1. Static Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.1. Static Lung and Chest Wall Mechanics.html", "keywords": "measurement composition gradients recoil ventilation compliance expiratory pressures pressure physiological pressure-volume pulmonary -- interactions surfactant surface spirometry diaphragm-abdomen change thorax cage chest lungs significance hysteresis volumes elastic the components maximum distensibility wall disease relationships mechanism tension total static inspiratory curve nature and volume capacities curves relaxation of rib hooke's during law lung"}, {"title": "11.03.2. Dynamic Lung and Chest Wall Mechanics", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.2. Dynamic Lung and Chest Wall Mechanics.html", "keywords": "inflation exhalation time airway transitional ventilation compliance expiratory laminar dynamic pressure effort-dependent pressure-volume equation effort-independent pressure-flow distribution types motion flow plateau gas rate resistance the turbulent isovolume frequency to limitation or frictional and regimens dependence airways poiseuille's peak curves constants nonelastic of effect cephalad tracheobronchial mechanics bias curve law in lung"}, {"title": "11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.3. Effects of Lung Compliance and Airway Resistance on Ventilation.html", "keywords": "auto-peep gradients trapping ventilation compliance pressure fatigue on pleural distribution inspired effective air gas energy resistance regional costs breathing ventilatory positive work pattern and weakness of muscular effect in"}, {"title": "11.03.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.03. Mechanics of Ventilation/11.03.4. Points to Remember.html", "keywords": ""}, {"title": "11.04. Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation.html", "keywords": "11 classification ventilation pressures pulmonary 4 04 space%2c physiology 3 points %26 alveolar gases md 1 to 05 ventilatory pattern%2c pattern and respiratory 2 partial of anatomy space dead remember medicine"}, {"title": "11.04.1. Partial Pressures of Respiratory Gases", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.1. Partial Pressures of Respiratory Gases.html", "keywords": ""}, {"title": "11.04.2. Classification of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.2. Classification of Ventilation.html", "keywords": "composition ventilation pressure hyperventilation physiological equation anatomical carbon measuring minute gas alveolar ratio dioxide to total or and volume of partial tidal space hypoventilation dead"}, {"title": "11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.04.3. Ventilatory Pattern, Dead Space, and Alveolar Ventilation.html", "keywords": ""}, {"title": "11.05.4. Points to Remember", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.04. Ventilation/11.05.4. Points to Remember.html", "keywords": ""}, {"title": "11.05. Pulmonary Function Measurements", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.05. Pulmonary Function Measurements.html", "keywords": ""}, {"title": "11.06. Pulmonary Blood Flow", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.06. Pulmonary Blood Flow.html", "keywords": ""}, {"title": "11.07. Gas Diffusion", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.07. Gas Diffusion.html", "keywords": ""}, {"title": "11.08. Oxygen Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.08. Oxygen Equilibrium & Transport.html", "keywords": ""}, {"title": "11.09. Carbon Dioxide Equilibrium & Transport", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.09. Carbon Dioxide Equilibrium & Transport.html", "keywords": ""}, {"title": "11.10 Acid-Base Regulation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.10 Acid-Base Regulation.html", "keywords": ""}, {"title": "11.11. Control of Ventilation", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.11. Control of Ventilation.html", "keywords": ""}, {"title": "11.12. Ventilation-Perfusion Relationships", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.12. Ventilation-Perfusion Relationships.html", "keywords": ""}, {"title": "11.13. Clinical Assessment of Acid-Base & Oxygenation Status", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.13. Clinical Assessment of Acid-Base & Oxygenation Status.html", "keywords": ""}, {"title": "11.14. Physiological Basis for Oxygenation and Lung Protection Strategies", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.14. Physiological Basis for Oxygenation and Lung Protection Strategies.html", "keywords": ""}, {"title": "11.15. Physiology of Sleep-Disordered Breathing", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.15. Physiology of Sleep-Disordered Breathing.html", "keywords": ""}, {"title": "11.16. Fetal & Newborn Cardiopulmonary Physiology", "url": "/Pulmonary Medicine/11. Respiratory Anatomy & Physiology/11.16. Fetal & Newborn Cardiopulmonary Physiology.html", "keywords": ""}, {"title": "12. Pulmonary Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms.html", "keywords": ""}, {"title": "13. Pulmonary Pathology", "url": "/Pulmonary Medicine/13. Pulmonary Pathology.html", "keywords": ""}, {"title": "Critical Care Medicine", "url": "/Critical Care Medicine.html", "keywords": "- metabolic surgery care surgery%2c ethics research%2c neurologic endocrine%2c ultrasound md research pharmacology trauma administration renal%2c critical | toxicology and transplantation trauma%2c scanning cardiovascular oncologic endocrine disorders renal topics hematologic medicine gastrointestinal"}, {"title": "Cardiovascular Disorders", "url": "/Critical Care Medicine/Cardiovascular Disorders.html", "keywords": ""}, {"title": "Critical Care Ultrasound Scanning", "url": "/Critical Care Medicine/Critical Care Ultrasound Scanning.html", "keywords": ""}, {"title": "Gastrointestinal Disorders", "url": "/Critical Care Medicine/Gastrointestinal Disorders.html", "keywords": ""}, {"title": "Hematologic and Oncologic Disorders", "url": "/Critical Care Medicine/Hematologic and Oncologic Disorders.html", "keywords": ""}, {"title": "Neurologic Disorders", "url": "/Critical Care Medicine/Neurologic Disorders.html", "keywords": ""}, {"title": "Pharmacology and Toxicology", "url": "/Critical Care Medicine/Pharmacology and Toxicology.html", "keywords": ""}, {"title": "Renal, Endocrine, and Metabolic Disorders", "url": "/Critical Care Medicine/Renal, Endocrine, and Metabolic Disorders.html", "keywords": ""}, {"title": "Research, Administration and Ethics", "url": "/Critical Care Medicine/Research, Administration and Ethics.html", "keywords": ""}, {"title": "Surgery, Trauma, and Transplantation", "url": "/Critical Care Medicine/Surgery, Trauma, and Transplantation.html", "keywords": ""}, {"title": "Signs & Symptoms", "url": "/Pulmonary Medicine/12. Pulmonary Symptoms/Signs & Symptoms.html", "keywords": "dyspnea 2 md 1 3 12 cough wheezing %26 pulmonary signs symptoms medicine"}]